Literature DB >> 11390614

p21cip1 Degradation in differentiated keratinocytes is abrogated by costabilization with cyclin E induced by human papillomavirus E7.

F Noya1, W M Chien, T R Broker, L T Chow.   

Abstract

The human papillomavirus (HPV) E7 protein promotes S-phase reentry in a fraction of postmitotic, differentiated keratinocytes. Here we report that these cells contain an inherent mechanism that opposes E7-induced DNA replication. In organotypic raft cultures of primary human keratinocytes, neither cyclin E nor p21cip1 is detectable in situ. However, E7-transduced differentiated cells not in S phase accumulate abundant cyclin E and p21cip1. We show that normally p21cip1 protein is rapidly degraded by proteasomes. In the presence of E7 or E6/E7, p21cip1, cyclin E, and cyclin E2 proteins were all up-regulated. The accumulation of p21cip1 protein is a posttranscriptional event, and ectopic cyclin E expression was sufficient to trigger it. In constract, cdk2 and p27kip1 were abundant in normal differentiated cells and were not significantly affected by E7. Cyclin E, cdk2, and p21cip1 or p27kip1 formed complexes, and relatively little kinase activity was found associated with cyclin E or cdk2. In patient papillomas and E7 raft cultures, all p27kip1-positive cells were negative for bromodeoxyuridine (BrdU) incorporation, but only some also contained cyclin E and p21cip1. In contrast, all cyclin E-positive cells also contained p27kip1. When the expression of p21cip1 was reduced by rottlerin, a PKC delta inhibitor, p27kip1- and BrdU-positive cells remained unchanged. These observations show that high levels of endogenous p27kip1 can prevent E7-induced S-phase reentry. This inhibition then leads to the stabilization of cyclin E and p21cip1. Since efficient initiation of viral DNA replication requires cyclin E and cdk2, its inhibition accounts for heterogeneous viral activities in productively infected lesions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11390614      PMCID: PMC114328          DOI: 10.1128/JVI.75.13.6121-6134.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  81 in total

1.  Interaction between cyclin-dependent kinases and human papillomavirus replication-initiation protein E1 is required for efficient viral replication.

Authors:  T Ma; N Zou; B Y Lin; L T Chow; J W Harper
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

2.  Complete inhibition of Cdk/cyclin by one molecule of p21(Cip1).

Authors:  L Hengst; U Göpfert; H A Lashuel; S I Reed
Journal:  Genes Dev       Date:  1998-12-15       Impact factor: 11.361

3.  Regulation of cyclin E transcription by E2Fs and retinoblastoma protein.

Authors:  Y Geng; E N Eaton; M Picón; J M Roberts; A S Lundberg; A Gifford; C Sardet; R A Weinberg
Journal:  Oncogene       Date:  1996-03-21       Impact factor: 9.867

4.  Cell-free degradation of p27(kip1), a G1 cyclin-dependent kinase inhibitor, is dependent on CDK2 activity and the proteasome.

Authors:  H Nguyen; D M Gitig; A Koff
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

5.  Regulation of p21WAF1/CIP1 expression by p53-independent pathways.

Authors:  Y X Zeng; W S el-Deiry
Journal:  Oncogene       Date:  1996-04-04       Impact factor: 9.867

6.  Regulation of the cyclin E gene by transcription factor E2F1.

Authors:  K Ohtani; J DeGregori; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

7.  Concordant induction of cyclin E and p21cip1 in differentiated keratinocytes by the human papillomavirus E7 protein inhibits cellular and viral DNA synthesis.

Authors:  Y Jian; B A Van Tine; W M Chien; G M Shaw; T R Broker; L T Chow
Journal:  Cell Growth Differ       Date:  1999-02

8.  Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes.

Authors:  S Cheng; D C Schmidt-Grimminger; T Murant; T R Broker; L T Chow
Journal:  Genes Dev       Date:  1995-10-01       Impact factor: 11.361

9.  Cyclin E2, a novel G1 cyclin that binds Cdk2 and is aberrantly expressed in human cancers.

Authors:  J M Gudas; M Payton; S Thukral; E Chen; M Bass; M O Robinson; S Coats
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

10.  Cell cycle-dependent regulation of human DNA polymerase alpha-primase activity by phosphorylation.

Authors:  C Voitenleitner; C Rehfuess; M Hilmes; L O'Rear; P C Liao; D A Gage; R Ott; H P Nasheuer; E Fanning
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

View more
  28 in total

1.  Human papillomavirus type 31 E5 protein supports cell cycle progression and activates late viral functions upon epithelial differentiation.

Authors:  Frauke Fehrmann; David J Klumpp; Laimonis A Laimins
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

2.  Increased sensitivity of HPV-positive head and neck cancer cell lines to x-irradiation ± Cisplatin due to decreased expression of E6 and E7 oncoproteins and enhanced apoptosis.

Authors:  Frank Ziemann; Andrea Arenz; Stefanie Preising; Claus Wittekindt; Jens P Klussmann; Rita Engenhart-Cabillic; Andrea Wittig
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

3.  Role of Cdk1 in DNA damage-induced G1 checkpoint abrogation by the human papillomavirus E7 oncogene.

Authors:  Xueli Fan; Jason J Chen
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 4.  Manipulation of cellular DNA damage repair machinery facilitates propagation of human papillomaviruses.

Authors:  Nicholas A Wallace; Denise A Galloway
Journal:  Semin Cancer Biol       Date:  2014-01-08       Impact factor: 15.707

5.  Conditionally activated E7 proteins of high-risk and low-risk human papillomaviruses induce S phase in postmitotic, differentiated human keratinocytes.

Authors:  N Sanjib Banerjee; Nicholas J Genovese; Francisco Noya; Wei-Ming Chien; Thomas R Broker; Louise T Chow
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

6.  Human papillomavirus E6E7-mediated adenovirus cell killing: selectivity of mutant adenovirus replication in organotypic cultures of human keratinocytes.

Authors:  C Balagué; F Noya; R Alemany; L T Chow; D T Curiel
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

7.  Downregulation of Cdc2/CDK1 kinase activity induces the synthesis of noninfectious human papillomavirus type 31b virions in organotypic tissues exposed to benzo[a]pyrene.

Authors:  Samina Alam; Brian S Bowser; Michael J Conway; Mohd Israr; Eric J Ryndock; Long Fu Xi; Craig Meyers
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

Review 8.  Viral oncogenes, noncoding RNAs, and RNA splicing in human tumor viruses.

Authors:  Zhi-Ming Zheng
Journal:  Int J Biol Sci       Date:  2010-12-01       Impact factor: 6.580

Review 9.  Human papillomavirus infections: warts or cancer?

Authors:  Louise T Chow; Thomas R Broker
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-07-01       Impact factor: 10.005

10.  Activation of adenovirus early promoters and lytic phase in differentiated strata of organotypic cultures of human keratinocytes.

Authors:  Francisco Noya; Cristina Balagué; N Sanjib Banerjee; David T Curiel; Thomas R Broker; Louise T Chow
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.